Literature DB >> 7750275

Bacitracin: a significant sensitizer in leg ulcer patients?

I Zaki1, L Shall, K L Dalziel.   

Abstract

We report the results of patch testing 85 patients with either long-standing venous ulceration or eczema complicating their leg ulcers. As previously reported, lanolin and its derivatives and topical antibiotics were the most frequent sensitizers. However, unlike previously published data, we found bacitracin to be the most potent sensitizer of all topical antibiotics tested. There were no positive reactions in a control group of patients, although we were unable to repeat the patch tests in patients with a positive reaction to bacitracin. In the past 10 years, our department has used a proprietary mixture of polymyxin and bacitracin in treating infected leg ulcers and other dermatoses. It is therefore possible that chronic usage of topical bacitracin on leg ulcers carries a significant risk of contact sensitization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7750275     DOI: 10.1111/j.1600-0536.1994.tb01924.x

Source DB:  PubMed          Journal:  Contact Dermatitis        ISSN: 0105-1873            Impact factor:   6.600


  3 in total

1.  Not all Polysporin products contain lidocaine.

Authors:  Bahar Bahrani; Joel DeKoven
Journal:  CMAJ       Date:  2018-01-22       Impact factor: 8.262

2.  Venous leg ulcers: Pathophysiology and Classification.

Authors:  Biju Vasudevan
Journal:  Indian Dermatol Online J       Date:  2014-07

3.  Summary of recommendations for leg ulcers.

Authors:  Sunil Dogra; Rishu Sarangal
Journal:  Indian Dermatol Online J       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.